BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2017 2:36:57 AM | Browse: 879 | Download: 1174
 |
Received |
|
2017-09-19 03:05 |
 |
Peer-Review Started |
|
2017-09-20 07:32 |
 |
To Make the First Decision |
|
2017-10-11 00:57 |
 |
Return for Revision |
|
2017-10-12 08:55 |
 |
Revised |
|
2017-10-26 02:44 |
 |
Second Decision |
|
2017-11-07 08:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2017-11-07 18:21 |
 |
Articles in Press |
|
2017-11-07 18:21 |
 |
Publication Fee Transferred |
|
2017-11-08 03:04 |
 |
Edit the Manuscript by Language Editor |
|
2017-11-11 07:23 |
 |
Typeset the Manuscript |
|
2017-11-17 07:07 |
 |
Publish the Manuscript Online |
|
2017-11-27 02:36 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Basic Study |
Article Title |
Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
MC Yu, Chao-Wei Lee, YS Lee, Jang-Hau Lian, Chia-Lung Tsai, Yi-Ping Liu, Chun-Hsing Wu and Chi-Neu Tsai |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Chang-Gung Memorial Hospital |
CMRPG 3C0951-3 |
Chang-Gung Memorial Hospital |
CMRPG 3A0671 |
Chang-Gung Memorial Hospital |
CMRPD3F0011 |
|
Corresponding Author |
Chi-Neu Tsai, PhD, Assistant Professor, Graduate Institute of Clinical Medical Sciences, 259 Wen-Hwa 1st Rd, Guishan Dist., Kwei-Shan 33302, Taoyuan, Taiwan. pink7@mail.cgu.edu.tw |
Key Words |
Early-stage hepatocellular carcinoma; Copy number aberration; Prognosis; OncoScan; Molecular inversion probe |
Core Tip |
In this paper, we report that patients with early-stage hepatocellular carcinoma presenting a higher percentage of genome change or copy number aberrations affecting MYC, ELAC2, SYK, GAK, MECOM, or WRN are predicted to have worse outcomes, and they should be intensively followed after resection. |
Publish Date |
2017-11-27 02:36 |
Citation |
Yu MC, Lee CW, Lee YS, Lian JH, Tsai CL, Liu YP, Wu CH, Tsai CN. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data. World J Gastroenterol 2017; 23(44): 7818-7829 |
URL |
http://www.wjgnet.com/1007-9327/full/v23/i44/7818.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v23.i44.7818 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345